Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2000
12/21/2000CA2376630A1 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
12/21/2000CA2376523A1 Dna pcv-vaccine
12/21/2000CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376288A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000CA2375619A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000CA2375423A1 Promoters from atlantic salmon
12/21/2000CA2375346A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy
12/21/2000CA2375320A1 Dna vaccines for pets or for animals used in sports
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2374678A1 Diagnosis, prognosis and treatment of cancer related to the barx2 gene
12/21/2000CA2374000A1 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus
12/20/2000EP1061129A1 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
12/20/2000EP1061085A2 Synthetic catalytic oligonucleotides
12/20/2000EP1060747A2 Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
12/20/2000EP1060741A1 Sustained release microspheres
12/20/2000EP1060261A1 Poly zinc finger proteins with improved linkers
12/20/2000EP1060259A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060247A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2000EP1060242A1 Purified populations of stem cells
12/20/2000EP1059931A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
12/20/2000EP1059929A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/20/2000EP0877555A4 Method of inhibiting immune system destruction of transplanted viable cells
12/20/2000CN1277636A High efficiency vetroviral rectors that contain none of viral coding sequences
12/20/2000CN1277634A New tissue-specific calpaines, their production and their use
12/20/2000CN1277616A Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
12/20/2000CN1277549A Vesicular complexes and methods of making and using the same
12/20/2000CN1059705C Composition for introducing nucleic acid complexes into higher eucaryotic cells
12/19/2000US6162897 17q-linked breast and ovarian cancer susceptibility gene
12/19/2000US6162796 Method for transferring genes to the heart using AAV vectors
12/19/2000US6162641 Nucleotide sequence derived from a promoter sequence and operably linked to a heterologous gene; for controlled gene expression
12/19/2000US6162630 Asp1
12/19/2000US6162618 Nucleotide sequence; recombinant production; diagnosis of infections; drug screening; bactericides; bacteriostats; enzyme inhibitors; vaccines
12/19/2000US6162435 A isolated protein for treating swine; a diagnostic test kit for detecting the presence of bacterial infection in swine herds
12/19/2000CA2203808C Hybrid adenovirus-aav virus and method of use thereof
12/14/2000WO2000075665A1 Early detection of flaviviruses using the ns1 glycoprotein
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075354A2 Adenoviral vectors encoding interferon and their use in gene therapy
12/14/2000WO2000075351A1 Siv-based packaging-defficient vectors
12/14/2000WO2000075347A2 Tet repressor-based transcriptional regulatory proteins
12/14/2000WO2000075342A1 Novel plasmid vector
12/14/2000WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000WO2000075329A1 Targeted angiogenesis
12/14/2000WO2000075326A1 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use
12/14/2000WO2000075321A2 Polynucleotides and membrane-bound polypeptide encoded thereby
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075312A1 Cd44 splice variant associated with rheumatoid arthritis
12/14/2000WO2000075309A1 Spliceosome protein and its use
12/14/2000WO2000075292A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/14/2000WO2000075291A2 Cells with enforced expression of bcl-xl
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075164A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075162A1 A compound containing a labile disulfide bond
12/14/2000WO2000074726A1 METHODS AND COMPOSITIONS FOR PREVENTING p53 MEDIATED APOPTOSIS
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074723A2 Methods for the gene therapy of benign prostatic hyperplasia and medical agents therefore
12/14/2000WO2000074722A2 Modification of biological elements
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074704A1 Transcription factors related to tfiia
12/14/2000WO2000074688A1 Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
12/14/2000WO2000074687A1 Antisense modulation of b7 protein expression
12/14/2000WO2000074686A1 Modulators of methylation for control of bacterial virulence
12/14/2000WO2000074646A2 Novel liposomal vector complexes and their use in gene therapy
12/14/2000WO2000074635A2 Delivery of single stranded dna for expression
12/14/2000WO2000074629A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/14/2000WO2000074485A1 Estrogen receptor site-specific ribozymes and uses thereof for estrogen dependent tumors
12/14/2000WO2000054651A3 Human tumor necrosis factor receptor-like genes
12/14/2000WO2000053776A3 Human kallikrein-like genes
12/14/2000WO2000053775A3 Prevention and treatment of viral infections
12/14/2000WO2000050588A3 Genes associated with diseases of the colon
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000050070A3 Preparation for the treatment of pigmentation disorders
12/14/2000WO2000049141A3 A method for production and delivery of a protein in vivo
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
12/14/2000WO2000047217A3 Protection of cells in connection with treatment with chemical agents
12/14/2000WO2000046386A3 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
12/14/2000WO2000043498A3 Human liver progenitors
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000033872A9 Method of and compositions for immunization with the pseudomonas v antigen
12/14/2000WO2000015264A9 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000CA2504679A1 Compositions and methods for the treatment of tumor
12/14/2000CA2501815A1 Compositions and methods for the treatment of tumor
12/14/2000CA2376939A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/14/2000CA2376790A1 Siv-based packaging-defficient vectors
12/14/2000CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins
12/14/2000CA2376663A1 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000CA2376055A1 Spliceosomal protein and its use
1 ... 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 ... 870